For the last couple of weeks, I’ve noticed regular half-page ads from Seniors4BetterCare.com asking us to contact our ...

In Q2, it brought in $11.3 billion in sales, 36% higher than a year prior, and it cranked up its annual revenue guidance for ...

Roche is narrowing its pipeline to 11 disease areas and continuing to invest in a targeted way, said Teresa Graham, chief ...

Among biopharma firms, size didn’t always correlate with the highest wages, a recently debuted analysis of ‘best’ pharma ...

Analyst Kostas Biliouris of BMO Capital maintained a Hold rating on BridgeBio Pharma (BBIO – Research Report), retaining the price target ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on BridgeBio Pharma (BBIO – Research Report) today and set a price target ...

Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Having banked $60 million from Eli Lilly in the spring, Aktis Oncology has now closed an upsized $175 million series B that ...

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

"This expansion represents a strategic investment in the future of Piramal Pharma Ltd. Filling the commercial manufacturing ...

Mankind Pharma plans to raise up to Rs 10,000 crore through non-convertible debentures and commercial papers. The board ...

With bipartisan support for price reductions, the upcoming election could reshape the future of prescription drug pricing in ...